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Infection of cattle with Neospora caninum may result in abortion or the birth of a congenitally infected calf. Vaccination with
live N. caninum protects against experimental infection of cattle and mice, and the naturally attenuated Nc-Nowra strain of N.
caninum is of particular interest as a potential vaccine candidate. Vaccination of heifers prior to breeding with live Nc-Nowra
tachyzoites by either the subcutaneous or the intravenous route reduced the rate of abortion and the presence of the parasite in
calves as determined by PCR and serology after infection of cows with a virulent isolate. Protected fractions were 55.6% to 85.2%
depending on the route of vaccination and growth conditions of the vaccine strain, with cryopreserved Nc-Nowra tachyzoites
being less effective, with a 25.9% protected fraction. Vaccination appeared to reduce the rate of pregnancy after artificial insemi-
nation in some groups compared to nonvaccinated, nonchallenged controls. One animal that was vaccinated but not challenged
experienced an abortion, but Nc-Nowra could not be detected in any of the cows in this group or their progeny. This study con-
firms that live vaccination can be an effective method of preventing neosporosis in cattle and yet highlights the technical hurdle
of preservation of live parasites that must be overcome for a vaccine to be commercially successful.
Neospora caninum is a protozoan parasite first identified in dogs
but now mostly recognized as being associated with fetal death
and abortion in midterm pregnant cattle (1). Although canids
such as dogs and dingoes are known to be definitive hosts for this
parasite (2), the main form of transmission among cattle is trans-
placental in utero from the dam to its fetus. Abortion and fetal loss
are the clinical manifestation of this route of transmission, as a
consequence of a recrudescent parasitemia occurring during preg-
nancy (3). Chronic, long-term infection by N. caninum of cattle is
widespread, occurring in many cattle-producing countries of the
world.
Abortion and fetal loss in cattle are one area of considerable
concern in the livestock industries, and a major proportion of the
losses can be attributed to infectious diseases, including neospo-
rosis (4). In Australia, for example, 1 to 5% of pregnant cattle
typically abort, with the major proportion of these being attrib-
uted to neosporosis. Mathematical modeling, including decision
tree analysis, has evaluated the potential for control of N. cani-
num-associated abortion in cattle, suggesting that vaccination is
the only realistic economical form of control (5). Test-and-cull,
where infected cattle are identified by serology and then removed
from breeding programs, is used infrequently on farms when vet-
erinary investigations are conducted into causes of abortion (6).
Despite the high cost of implementing test-and-cull programs,
and in the absence of an efficacious vaccine, it currently remains
the only option available to cattle producers.
The development of vaccines against neosporosis has been dis-
cussed previously (7). A killed vaccine (NeoGuard; Intervet/Sche-
ring Plough), based on inactivated tachyzoites, was developed pre-
viously (8, 9) but did not gain widespread acceptance due to
doubts on efficacy. An alternative approach being considered,
which is based on the injection of live tachyzoites before preg-
nancy, relies on the observation that protective immunity that
prevents fetal death and abortion can be induced in cattle (10, 11).
Such immunity is thought to be mediated by cell-mediated im-
mune mechanisms such as those associated with gamma inter-
feron (IFN). Vaccines based on recombinant proteins may also be
possible. One emerging formulation uses cyclophilin as the im-
munogen, giving rise to increased levels of gamma interferon and
protective immunity in a nonpregnant mouse model (12).
The study described here aimed to investigate further the prac-
ticalities of live vaccination against neosporosis in cattle. Using the
Nc-Nowra isolate of N. caninum, the effect of the route of admin-
istration of a live formulation was investigated in a “vaccinate and
challenge model of fetal death” similar to the one described by
Williams et al. (11). Subcutaneous and intravenous routes of in-
jection of live Nc-Nowra tachyzoites were compared for their abil-
ity to protect against a fetopathic challenge given during preg-
nancy. A frozen and thawed preparation of tachyzoites was also
included in the study to assess the potential for preservation of a
live parasite vaccine. The results provide further evidence on the
efficacy of a live vaccine approach for the prevention of Neospora-
associated abortion and fetal death in cattle. The limitations of a
live vaccine against neosporosis in cattle are also discussed.
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All procedures involving animals were approved by the Institutional An-
imal Care and Use Committee of Thomas D. Morris, Inc., where the trial
was conducted. One hundred ten beef heifers approximately 16 months of
age were located and purchased by Thomas D. Morris, Inc., and screened
for antibodies to N. caninum by competitive enzyme-linked immunosor-
bent assay (cELISA) conducted at the Washington Animal Disease Diag-
nostic Laboratory at the College of Veterinary Medicine at Washington
State University in Pullman, WA.
Animals and trial design. Ninety-six animals that were never vacci-
nated against N. caninum and demonstrated 30% inhibition in the
cELISA were chosen for inclusion in the study. On day 0, all heifers were
randomly allocated into 7 groups (6 groups of 15 animals and 1 group of
6 sentinel animals). All animals except those allotted to groups 1 and 5 and
the sentinels (NTX) were vaccinated with 1  107 N. caninum Nc-Nowra
tachyzoites either subcutaneously or intravenously as described in the
study design (Table 1). Heifers in group 5 were vaccinated on day 1 using
a frozen and thawed parasite suspension containing 1  107 tachyzoites/
ml. All animals received 1 ml of vaccine or placebo. Heifers were vacci-
nated once against infectious bovine rhinotracheitis (IBR) virus, parain-
fluenza virus type 3 (PI3), bovine respiratory syncytial virus (BRSV), and
bovine viral diarrhea (BVD) virus types 1 and 2 with Bovi-Shield Gold FP5
(Pfizer Animal Health) 21 days prior to vaccination with N. caninum. The
animals were maintained on pasture until just prior to challenge, at which
time they were transported to a biosafety level 2 facility. At 327 days
postvaccination, animals were moved to a separate necropsy facility.
Estrus was synchronized by intramuscular injection of 6 ml of Lutalyse
on day 49 after vaccination, followed by a second dose on day 60 postvac-
cination. Heifers were bred by artificial insemination approximately 72
and 80 h following the second Lutalyse injection, were monitored for signs
of standing estrus for up to 10 days, and were bred again if estrus appeared.
Breeding occurred from days 63 through 75 postvaccination, with some
animals bred up to 5 times. Heifers were examined by ultrasound at 120
days postvaccination (approximately 57 days of gestation) to determine
pregnancy status by detection of fetal heartbeat and/or movement. Heif-
ers were reexamined for pregnancy status on days 138, 167, 195, and 223
postvaccination.
On day 139 postvaccination, confirmed pregnant heifers, except for
those in group 2 and NTX, were challenged by intravenous administration
of 1 ml of parasite suspension containing 1.2  106 N. caninum Nc-S197
tachyzoites/ml. Twenty-five heifers that never became pregnant were eu-
thanized on day 140. In addition, one heifer from each of groups 1 and 2
which were pregnant initially but found to be open after day 121 and two
pregnant heifers from group 2 were euthanized on day 140. The repro-
ductive tracts were removed and examined grossly for evidence of re-
sorbed pregnancies. Uterine and oviduct samples from each heifer were
placed in formalin for histopathological examination. Specimens were
submitted to the Borgess Research Institute, Medical Device Research
Laboratory, Portage, MI, for processing to slides. Tissues were stained
with hematoxylin and eosin, and sections were examined by light micros-
copy. Blood was collected for measurement of antibodies on days 138,
167, and 195 postvaccination. After challenge, animals were observed at
least once daily for signs of estrus or abortion. Aborted fetuses and/or
placentas; spleen, heart, lung, and liver; and rostral, temporal, and occip-
ital sections of the cerebellum, cerebrum, brain stem, and spinal cord were
collected where possible and frozen at 80°C. Blood was collected from
any heifer that aborted at the time of abortion and again 2 to 3 weeks later.
On days 334 and 336 postvaccination, all remaining pregnant heifers were
euthanized. Fetuses were removed, a blood sample was collected from
each fetus, and the fetuses were euthanized. Samples of spleen, heart, lung,
and liver and rostral, temporal, and occipital sections of the cerebellum,
cerebrum, and brain stem were collected from each fetus and frozen at
80°C. In addition, brain tissue from eight heifers in each of group 1
(nonvaccinated, challenged) and group 2 (vaccinated, nonchallenged)
was collected for mouse bioassay and PCR for detection of Neospora cani-
num. Sampling of heifers comprised 5 g of tissue from each of the left and
right rostral, temporal, and occipital lobes of the cerebrum, cerebellum,
and brain stem/spinal cord.
Nc-Nowra cell culture. Neospora caninum Nc-Nowra was maintained
on Vero cells grown in either RPMI medium (Sigma catalog no. R5885)
with 2% equine serum (Quad Five catalog no. 262-500) and 1% L-glu-
tamine (Gibco catalog no. 25030) and antibiotics (penicillin-streptomy-
cin solution; Gibco catalog no. 15140-122) or a proprietary minimal es-
sential medium (PMEM) supplemented with 1% bovine serum (JRH
Biosciences; catalog no. 12107-1000 M) and antibiotics. To prepare the
vaccine culture, frozen seed stock of N. caninum Nc-Nowra was thawed at
37°C and added to monolayers of host cells grown in tissue culture flasks.
The culture medium was removed and replaced with fresh medium 6 to 8
h after infection. The medium was replaced every 3 to 4 days if needed
until tachyzoites were observed breaking out of the host cells. The cells
and tachyzoites were then harvested by removing the cell layer with a
sterile cell scraper and centrifuging the resulting suspension of cells and
tachyzoites for 15 min at 1,000  g. The pellet was resuspended in 5 ml of
Hanks’ balanced salts solution (Gibco catalog no. 14170-112) supple-
mented with 20 mM HEPES buffer (Gibco 15630-080) (HBSS-HEPES),
and remaining host cells were disrupted with a stomacher (Seward model
80). The number of tachyzoites was determined by direct count. The
suspension was then used to further passage the parasite culture for am-
plification. The vaccine was prepared from a pooled suspension from
multiple flasks after two passages, adjusted to contain 1  107
tachyzoites/ml as determined by direct count.
Parasites for vaccination of group 5 were frozen at 80°C at 1  108
tachyzoites/ml in HBSS-HEPES with 3.5% bovine serum albumin and
15% dimethyl sulfoxide (DMSO). This formulation was demonstrated to
yield 50 to 90% viability after a 80°C freeze-thaw cycle (results not
shown), although the viability of the vaccine preparation used in this
study was not determined. After harvest, counting, and centrifugation of
tachyzoites, the pellet was resuspended in 2.5 ml of cryopreservative so-
lution, held at 4°C for 1 h and 10°C for 2 h, and then transferred to
80°C and held overnight. The frozen preparation was thawed in a 37°C
water bath and diluted to 25 ml with HBSS-HEPES to obtain a final con-
centration of 1  107 tachyzoites/ml. The concentration of tachyzoites
was confirmed by direct count, and the vaccine culture was administered
to animals within 2 h of thawing.
Challenge strain. The challenge strain Neospora caninum Nc-S197
was isolated from the brain of a congenitally infected calf from a U.S. beef
herd suffering from an outbreak of neosporosis in 1997. The calf died
shortly after birth; brain tissue was removed, homogenized, and injected
intraperitoneally into scid/beige mice; and the parasite was subsequently
isolated from the lung into culture. The organism was propagated for 10 in
vitro passages and then frozen as working stock. Parasites were cultivated
on MA104 cells growing in Opti-MEM medium (Gibco catalog no.
31985-070) supplemented with 5% fetal bovine serum (JRH Biosciences
catalog no. 12107-1000 M) and antibiotics (penicillin-streptomycin solu-
tion; Gibco catalog no. 15140-122). Parasites were passaged and harvested
TABLE 1 Study design and vaccination protocola
Treatment
group Vaccination culture and regimen. Challenged
1 Saline placebo, day 0 Y
2 Nc-Nowra, i.v., RPMI medium, day 0 N
3 Nc-Nowra, i.v., RPMI medium, day 0 Y
4 Nc-Nowra, s.c., RPMI medium, day 0 Y
5 Nc-Nowra, s.c., RPMI medium, frozen/thawed,
day 1
Y
6 Nc-Nowra, i.v., PMEM, day 0 Y
NTX None N
a Abbreviations: i.v., intravenously; s.c., subcutaneously; Y, yes; N, no.
Weber et al.
100 cvi.asm.org Clinical and Vaccine Immunology
 on F


























as described above. The challenge culture was pooled from multiple flasks
and adjusted to 1.2  106 tachyzoites/ml in HBSS-HEPES after 4 passages
in vitro.
ELISA. Antibodies to N. caninum in serum samples taken from heifers
during the trial were assayed by a direct ELISA. Soluble antigen was pre-
pared by subjecting tachyzoites of N. caninum strain PB-1-2c to three
freeze-thaw cycles followed by sonication and centrifugation to remove
cell debris. The solution was adjusted to contain 1 mg protein/ml, and
protease inhibitors were added. Nunc Maxisorp plates were coated with
200 ng protein per well after dilution in 0.01 M sodium tetraborate buffer.
Plates were blocked for 2 h at 37°C with 1% casein in Dulbecco’s phos-
phate-buffered saline (DPBS). Serum samples were diluted in 1% casein-
DPBS and added to the plates, and then the plates were incubated for 1 h
at 37°C. After three washes with DPBS-0.05% Tween 20, peroxidase-con-
jugated goat anti-bovine IgG (KPL catalog no. 14-12-06 or Jackson Lab-
oratories catalog no. 101-035-003) diluted 1:3,000 in 1% casein-DPBS
was added to each well, and the plates were incubated for 1 h at 37°C.
Plates were washed again, and 100 l of peroxidase substrate (KPL catalog
no. 50-62-00) was added to each well. Plates were then incubated at room
temperature, and the optical density (OD) of each well was read at 405
nm. A sample was considered positive if the OD was greater than that of
the average OD plus 3 standard deviations of the negative-control serum.
Pretrial serum samples and samples of fetal fluids were assayed by com-
petitive ELISA (cELISA) at the Washington Animal Disease Diagnostic
Laboratory at the College of Veterinary Medicine at Washington State
University in Pullman, WA.
Molecular assays. To detect parasites in tissues by PCR, frozen fetal
tissue and heifer brain samples were thawed and diced with scissors, and a
5-g sample was added to 20 ml of saline. The mixture was homogenized in
a stomacher (Seward model 80) to yield a 20% suspension of tissue. Total
DNA was extracted from 100 l of the suspension using Qiagen DNeasy
extraction kits. The extracted DNA was subjected to a nested PCR diag-
nostic assay for detection of N. caninum DNA. Primers were designed to
detect the NC5 diagnostic gene sequence (13) and are provided in Table 2.
For the outer reaction, 1 unit of Platinum Taq DNA polymerase (Invitro-
gen catalog no. 10966-026), 1.5 mM MgCl2, 0.2 mM deoxynucleoside
triphosphates (dNTPs) (Invitrogen catalog no. 18427-103), 0.4 M
(each) primer, and 2 l of template DNA were combined in a total volume
of 50 l. Reactions were performed in 96-well plates sealed with a pierce-
able aluminum seal (AlumaSeal II pierceable sealing film for PCR; Excel
Scientific catalog no. AF100), and reaction products were diluted 1:10 in a
second 96-well tray before being transferred into a third 96-well tray con-
taining the reaction mix for the inner PCR. The inner reaction mixture
contained 25 l of PCR Master Mix (Applied Biosystems catalog no.
4304437), 0.6 M (each) primer, and 5 l of 10-fold-diluted product
from the first reaction in a total volume of 50 l. The reaction conditions
are provided in Table 3. The products of the second reaction were exam-
ined on 2% agarose 48-well e-gels (Invitrogen catalog no. A10571) for the
presence of bands of the expected size. In order to differentiate between
the vaccine and challenge strains, a PCR assay based on the MS10 micro-
satellite sequence (GenBank accession number CF659321) was used for
selected samples. This sequence exhibits a high degree of length polymor-
phism between Neospora strains (14). A nested PCR assay for detection of
the sequence (15) was adapted for use with the Nc-Nowra and S197 strains
by using a pair of primers described in reference 16. The inner and outer
primer pairs are listed in Table 2. The reaction mixture used for the outer
reaction was the same as that used for the outer reaction of the NC5 assay.
The reaction mixture for the inner reaction was identical with the excep-
tion of the use of 2 mM MgCl2 instead of 1.5 mM. Using 4% agarose e-gels
(Invitrogen catalog no. G5018-04), the products of the nested PCR from
the two strains could be readily distinguished based on the difference in
their size. All PCRs were carried out in a Bio-Rad C1000 thermal cycler.
In order to determine whether vaccination with live N. caninum Nc-
Nowra resulted in active infection in the brains of vaccinated animals,
brain tissue samples from the vaccinated, nonchallenged group (group 2)
were examined for the presence of parasite DNA by diagnostic PCR and
for the presence of viable parasites by mouse bioassay (see below). Brain
tissue samples from the nonvaccinated, challenged group (group 1) were
also examined in these assays. In addition, serum samples from selected
heifers in groups 1 and 2 were examined by diagnostic PCR to detect the
presence of parasite DNA. If parasite DNA was detected by diagnostic
PCR in any of the samples, the sample was also tested in the microsatellite
nested PCR assay to confirm the identity of the parasite strain.
Bioassay. A bioassay using interferon-knockout (IFN-KO) mice
(Jackson Laboratories; B6.129S7-IFNgtm1ts/J) was used to detect Neospora
caninum in brain tissue of six nonvaccinated, challenged cows (group 1)
and eight vaccinated, nonchallenged cows (group 2). Brain tissue was
collected and homogenized as described above, and samples of homoge-
nates from the different brain regions (left and right rostral, temporal, and
occipital lobes of the cerebrum, the cerebellum, and the brain stem/spinal
cord) were pooled to provide a single sample from each animal. The
pooled samples were treated with trypsin (0.05% final concentration; In-
vitrogen catalog no. 15400054) at 37°C for 30 min. The suspension was
centrifuged and washed twice in DPBS, and the pellet was resuspended in
a volume of saline containing antibiotics (1,000 IU of penicillin and 100
g streptomycin per ml; Gibco catalog no. 15140-122) resulting in a 10
concentration of the original homogenate. The particle size of the suspen-
sion was reduced by repeated aspiration through successively smaller nee-
dles, starting with 18 or 20 gauge and working down to 23 to 25 gauge.
After acclimation, mice were weighed and injected intraperitoneally with
1 ml of concentrated brain homogenate, saline, or 1  104 Nc-Nowra or
Nc-S197 tachyzoites grown in cell culture as described above. Each prep-
aration was given to 3 mice. Mice were observed twice daily for clinical
signs of neosporosis (tetraplegia, ataxia, failure to groom, and abnormal
behavior consistent with neurological damage) and weighed once weekly
to monitor weight gain/loss. Mice that exhibited symptoms of neosporo-
sis or loss of 10% of their body weight from the previous week were
TABLE 2 Primers used for diagnostic and microsatellite PCR
Target sequence Forward Reverse Expected product size (bp)
NC5 outer 5=-GGT TGT GTT TGG CTG TGA AGG ACA-3 5=-CCA TTC ATC ACT GCC ACC ACG AAT-3 1,035
NC5 inner 5=-CAG GGT GAG GAC AGT GTG TAC AT-3= 5=-GTC CGC TTG CTC CCT ATG AA-3= 110
MS10 outer 5=-TCG TCG GAC ACA AAA GTG AG-3 5=-CCT TTC TCT CTT CCT ATA GC-3= 460
MS10 inner 5=-CCC TCG TGT CGT ACT CGT AG-3 5=-CCC TGT TTG ACG TAG ATT GA-3 148 (Nc-Nowra), 139 (S197)
TABLE 3 Reaction conditions for PCR
Step
NC5 MS10
Outer Inner Outer Inner
1 94°C, 1 min 94°C, 1 min 94°C, 1 min 95°C, 1 min
2 94°C, 30 s 94°C, 30 s 94°C, 30 s 95°C, 30 s
3 60°C, 30 s 55°C, 30 s 55°C, 30 s 60°C, 30 s
4 68°C, 1 min 68°C, 30 s 68°C, 30 s 72°C, 30 s
5 Repeat steps 2 to
4 34 times
Repeat steps 2 to
4 34 times
Repeat steps 2 to
4 34 times
Repeat steps 2 to
4 34 times
6 68°C, 5 min 68°C, 5 min 68°C, 5 min 72°C, 5 min
7 Hold 4°C Hold 4°C Hold 4°C Hold 4°C
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euthanized, and brain, lung, heart, and liver samples were collected and
frozen for analysis by PCR to detect the presence of Neospora. The study
was terminated 8 weeks after injection, at which time all remaining mice
were euthanized and blood, brain, lung, and liver samples were collected.
Because of their small size, heart and lung were combined into a single
sample. Tissue samples were processed, and DNA was extracted as de-
scribed for bovine tissue. Blood was processed to serum and assayed for
the presence of antibodies to Neospora by direct ELISA. The bovine brain
homogenates given to mice were also examined for the presence of para-
sites by nested PCR using the NC5 diagnostic assay described above.
Statistical analysis. The 10% level of significance (P  0.10) was used
in statistical comparisons. Since the study used a relatively small number
of animals, the slightly higher level of risk associated with the 10% level of
significance compared to 5% was deemed acceptable. The percentage of
animals with Neospora-induced abortion and/or infection was the vari-
able of primary interest. The incidence of pregnancy rates was analyzed
using Fisher’s exact test to compare treatment differences. The incidence
of animals with fetuses infected with N. caninum or aborted was also
analyzed using Fisher’s exact test. The procedure “Proc Binomial” from
StatExact was used to calculate the prevented fractions and 90% confi-
dence intervals for each vaccinated treatment group compared to the non-
vaccinated, challenged control group. For categorical laboratory assay
data, pregnancy data, and fetal protection data, the number and percent-
age of animals in each categorical class were summarized by treatment and
time point as well as by treatment across time points.
RESULTS
Pregnancy, seroconversion, and histopathology. Although each
group initially comprised 15 vaccinated, pregnant animals, the
number of animals in each group changed as the study pro-
gressed. One animal in group 2 was found dead the morning
following vaccination. This animal had acute cardiopulmonary
congestion that was attributed to anaphylaxis, which likely
played a role in the death of the animal. A second group 2 heifer
was inadvertently challenged and moved to group 3. Thus, on
the day of challenge there were 13 animals in group 2 and 16
animals in group 3 (Table 4).
Differences in pregnancy rates were observed at 75 days of
gestation (Table 4). Both groups receiving subcutaneous vaccine
grown in RPMI medium (groups 4 and 5) and the group receiving
the vaccine grown in PMEM intravenously (group 6) had signifi-
cantly lower pregnancy rates than did the saline control group. Of
the 39 animals vaccinated intravenously with freshly prepared
tachyzoites, 29 (groups 2, 3, and 6) had seroconverted by day 139
postvaccination (75 days of gestation) based on direct ELISA re-
sults (Table 4). Ten of 15 animals vaccinated with fresh material by
the subcutaneous route seroconverted, but only one of the 15
animals receiving the frozen and thawed vaccine seroconverted.
Unvaccinated animals (group 1 and sentinels) were seronegative
prior to challenge on day 139.
Histopathology conducted on samples collected on day 140
postvaccination from nonpregnant animals revealed lesions of
potential clinical significance in two of them. One animal from
group 5 had subacute inflammation and formation of lymphoid
nodules within the lamina propria of the oviduct, and one from
group 6 had granulomatous inflammation of the uterus; however,
no fetal remains or microorganisms were observed. No significant
lesions were observed in any other samples from nonpregnant
animals. The two pregnant heifers from group 2 that were eutha-
nized prior to challenge had no significant lesions in the oviduct or
uterus. One of the two heifers lost a fetus prior to sampling and
had returned to estrus. No significant gross lesions were found in
the fetus from the remaining heifer. No significant lesions were
seen in any other heifers that were sampled for histopathology.
Abortion and fetal infection. A fetus was considered infected
if it was either aborted or resorbed during the study, as indicated
by a previously confirmed pregnant heifer being open (nonpreg-
nant) at the end of the study. A fetus was also considered infected
if it was recovered and was positive for in utero exposure to N.
caninum indicated by the presence of parasite DNA in fetal tissues
as determined by PCR or the presence of antibodies to N. caninum
in body fluids as determined by cELISA. Although 16 fetuses were
missing at the end of the study and presumably aborted/resorbed,
only 5 were recovered for diagnostic evaluation. All 5 were nega-
tive for Leptospira, Brucella abortus, and IBR virus. Two more
fetuses were recovered from a heifer in group 6 that was carrying
twins, one of which was stillborn. This fetus was positive for BVD
virus in the liver by fluorescent-antibody (FA) test, but its surviv-
ing twin was negative. All other fetal serum and fluid samples were
negative for BVD virus.
Of the 14 pregnant cows in the saline control group (group 1),
two were euthanized prior to challenge to collect samples for his-
topathology of the uterus. Of the remaining 12 pregnant animals
that were challenged, nine aborted their fetuses (Table 5). Of the
two aborted fetuses that were recovered, one was seropositive and
both had PCR-positive brain tissue. The three surviving fetuses
were negative in both assays. Two group 2 animals (vaccinated,
not challenged) were euthanized prior to challenge for collection
of histopathology samples, reducing the number challenged to 9.
Eight of the 9 fetuses in this group remained viable throughout the
study, and all were negative for N. caninum exposure by serology.
TABLE 4 Pregnancy and prechallenge seroconversion ratesa
Treatment
group Vaccination Challenged No. pregnant/total (%)b




1 Saline Y 14/15 (93.3) A 0/13d 5/5
2 i.v., RPMI medium N 11/13c (84.6) A, C 8/10d 8/8
3 i.v., RPMI medium Y 12/16c (74) A, D 14/14 9/9
4 s.c., RPMI medium Y 9/15 (60) B, C, D, E 10/15 7/8
5 s.c., RPMI medium, frozen Y 9/15 (60) B, C, D, E 1/15 4/5
6 i.v., PMEM Y 7/15 (46.7) B, D 15/15 6/6
NTX None N 6/6 (100) A, E 0/6 0/6
a Seroconversion was determined by cELISA. Abbreviations: i.v., intravenous; s.c., subcutaneous; Y, yes; N, no; seropos., seropositive.
b Values followed by dissimilar capital letters are significantly different (P  0.10).
c One animal in group 2 was inadvertently challenged and moved into group 3; a second heifer in group 2 died shortly after vaccination.
d One pregnant heifer was euthanized for histopathology of the reproductive tract.
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Parasite DNA was found in spleen from one fetus, but this was
later determined to originate from the challenge strain Nc-S197
rather than the Nc-Nowra vaccine strain. The single aborted fetus
was not recovered, precluding any diagnostic testing. Ten of the 12
viable fetuses in the group vaccinated intravenously with Nc-
Nowra tachyzoites prepared from cells grown in RPMI medium
(group 3) survived challenge, contained no detectable antibodies
to Neospora, and were PCR negative. The single recovered aborted
fetus contained parasite DNA in lung, brain, and placenta. Among
the group vaccinated with this preparation subcutaneously (group
4), eight of nine fetuses survived, with two of the eight survivors
containing parasite DNA in placenta, brain, and heart. Six of the
nine viable fetuses in the group receiving the frozen vaccine
(group 5) survived to study termination. Parasite DNA was de-
tected in the lung of one of them and the placenta associated with
a second fetus, but all were seronegative. The two recovered
aborted fetuses contained parasite DNA in the placenta, one also
contained parasite DNA in the brain, and the other was PCR pos-
itive in liver, heart, lung, and spinal cord. All fetuses in the group
vaccinated with tachyzoites grown in PMEM (group 6) remained
viable, and one heifer contained two fetuses, both of which were
seropositive (Table 5). The remaining fetuses showed no evidence
of exposure in utero. The fraction of animals that were protected
by vaccination ranged from 55.6% to 85.2% for groups receiving
freshly prepared vaccine and 25.9% for the group receiving the
frozen vaccine (Table 5). All fetuses in the sentinel group (NTX)
remained viable throughout the study, and no evidence of expo-
sure to N. caninum was found in the fetuses.
Strain differentiation by PCR. Titration of genomic DNA
from Nc-S197 and Nc-Nowra strains in the microsatellite PCR
assay revealed a small but detectable difference in product size,
with the Nc-Nowra product being slightly larger than the S197
product (Fig. 1). Parasite DNA could be detected for both strains
down to 0.4 ng per reaction mixture, and as little as 0.04 ng per
reaction mixture could be detected for Nc-S197. This amount of
DNA is equivalent to approximately 400 tachyzoites (16). Two
vaccinated, nonchallenged heifers had PCR-positive brain tissue
samples; however, the size of the product obtained was consistent
with that of the Nc-S197 challenge strain (Fig. 2A). No PCR prod-
ucts of a size consistent with Nc-Nowra were obtained from any
heifer brain tissue or serum sample (Fig. 2A and B).
Parasite detection by bioassay. Within 1 h after intraperito-
neal injection of brain tissue homogenates into IFN-KO mice, all
mice exhibited signs of distress, including a hunched appearance
and lethargy. The mice recovered from these initial symptoms
within 24 h, however. Two mice that received tissue from a non-
vaccinated, challenged heifer died at 2 and 5 days after injection of
brain homogenate, respectively, without apparent clinical signs.
Two additional mice given tissue homogenate from two other
heifers in this group were found dead within 6 days after injection
of brain homogenates, also with no apparent clinical signs. Two
mice receiving brain homogenate from two separate vaccinated,
nonchallenged heifers died within 9 days of injection. One of the
mice injected with Nc-S197 exhibited lethargy and tremors at day
9 postinjection, and all three mice in this group were euthanized
for tissue collection. All mice in this group had positive livers, one
mouse also had positive heart-lung samples, and parasites were
detected in the brain of another mouse. One mouse injected with
Nc-Nowra was euthanized at 7 days postinjection as a result of loss
of 10% of its body weight from the initial weight on day 0. A
second mouse in this group was found dead the following day, and
the third mouse was euthanized because it was lethargic and ataxic
and was exhibiting tremors. The liver, heart-lung, and brain sam-
ples of all mice infected with the Nc-Nowra strain were positive for














1 Saline Y 3/12 (25) 2 1/4d 9/12 (75) A NA
2 i.v., RPMI medium N 8/9 (88.9) 0 0/8 1/9 (11.1) B, C 85.2 (44.8–99.0)
3 i.v., RPMI medium Y 10/12 (83.3) 1 0/9 2/12 (16.7) B, C 77.8 (39.1–96.3)
4 s.c., RPMI medium Y 8/9 (88.9) 0 0/8 3/9 (33.3) B, C 55.6 (5.0–85.2)
5 s.c., RPMI medium, frozen Y 6/9 (66.7) 2 0/5 5/9 (55.6) A, C 25.9 (31.5–68.3)
6 i.v., PMEM Y 8/8 (100)e 2 (twins) 1/8f 1/8 (12.5) B, C 83.3 (28.9–98.8)
NTX None N 6/6 (100) 0 0/6 0/6 (0)g NA
a Abbreviations: i.v., intravenous; s.c., subcutaneous; Y, yes; N, no; CI, confidence interval; NA, not applicable.
b Values followed by dissimilar capital letters are significantly different (P  0.10).
c Number of abortions or open heifers plus number of calves PCR positive and/or seropositive.
d One nonviable calf was sampled at necropsy.
e One cow had two fetuses.
f Both twins were seropositive but were counted as a single event because the cow was the experimental unit.
g NTX results were not included in the statistical analysis.
FIG 1 Detection and differentiation of Nc-S197 and Nc-Nowra genomic
DNA by MS10 nested PCR with a 4% agarose gel and ethidium bromide
staining.
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Neospora by NC5 diagnostic PCR. The remaining mice were all
PCR negative for all tissues.
DISCUSSION
Vaccination of heifers with 107 tachyzoites of the Nc-Nowra strain
of N. caninum by either the intravenous or the subcutaneous route
provided a degree of protection from subsequent challenge with
the Nc-S197 strain. The incidence of infection in the offspring of
vaccinated cows as measured by abortion, serology, or detection
of parasite DNA in tissues was significantly reduced in all vacci-
nated groups with the exception of the frozen and thawed vaccine.
In addition to reducing the incidence of abortions, vaccination
also reduced transplacental transmission of the parasite. Most of
the calves from vaccinated cows were healthy and showed no ev-
idence of infection at the end of the trial. This result is consistent
with that of Williams et al. (11), who demonstrated complete pro-
tection of cows from abortion after challenge with the virulent
Nc-Liverpool strain among animals vaccinated with the Nc-
Nowra strain by the intravenous route. In the present study, in-
travenous and subcutaneous routes provided roughly equivalent
protection against challenge in that there was no significant dif-
ference in the degree of protection. Since most cattle vaccines are
administered subcutaneously, this result suggests that a vaccine
based on the Nc-Nowra strain could be administered in a manner
consistent with current vaccination practices.
The single abortion observed in the group that was vaccinated
but not challenged raises the possibility that the Nc-Nowra strain
retains some degree of virulence. No evidence of infection with
Nc-Nowra was found in any of the remaining calves or in the
brains of the vaccinated, unchallenged cows. Since no evidence of
infection was found in the brains of the nonvaccinated, challenged
cows, however, this result may reflect limitations of the methods
of detection rather than absence of infection. The results are fur-
ther complicated by the presence of DNA from the challenge
strain Nc-S197 in calf and cow tissues from the vaccinated, non-
challenged group and in a serum sample from a nonvaccinated,
noninfected sentinel heifer. Although this might suggest some
horizontal transfer of the challenge strain, a more likely explana-
tion is cross-contamination of samples during either necropsy,
sample processing, or conduct of PCRs. Although steps to avoid
such cross-contamination were taken, the high sensitivity of
nested PCRs enables the method to detect very small amounts
of contaminating DNA. In any case, further studies on the degree
of attenuation and safety in pregnant cattle of the Nc-Nowra
strain will be required before it can begin to be commercialized.
Tachyzoites preserved by freezing at 80°C in DMSO did not
induce the same degree of protection as did live tachyzoites that
were not frozen. Although the viability of the frozen vaccine prep-
aration used in this study was not determined due to logistical
constraints, results in our laboratory demonstrated that a high
degree of viability (50 to 90%) could be retained using the freezing
procedure described. Viability assessments were based on an in
vitro cell invasion assay, and the ability of such an assay to predict
parasite survival, replication, and immunogenicity in the cow is
uncertain. Preservation of the parasite in a form robust enough to
be infective and/or immunogenic is a major technical hurdle for
an effective live vaccine to prevent neosporosis in cattle.
An interesting observation in this study was the reduced pre-
challenge pregnancy rates in certain groups compared with the
nonvaccinated control. Both groups receiving subcutaneous vac-
cine prepared in RPMI medium, either frozen or nonfrozen, had
reduced pregnancy rates. The group receiving the RPMI medium
vaccine by the intravenous route had a pregnancy rate similar to
that of the nonvaccinated control group. This observation may
lead to speculation that the effect was route dependent, with the
intravenous route being tolerated better than the subcutaneous
route. The group vaccinated intravenously with vaccine prepared
in a different medium also exhibited a reduced rate of pregnancy,
however. Unless the medium used to prepare the vaccine also had
an impact on pregnancy rate independent of the effect of route of
administration, it is difficult to reconcile these results. A larger
study will be required to determine if there is an interaction be-
tween route of administration, growth medium, and conception
rate. The presence of antibody to BVD virus in one tissue of one
aborted fetus that was part of a set of twins is a somewhat anom-
alous observation. It would be expected that in the presence of a
BVD infection, there would be other positive samples, especially
from the twin of the fetus with the BVD-positive liver. The possi-
bility of a false-positive laboratory result cannot be excluded. It is
well established that vaccines do not generally provide 100% pro-
tection, and so it is conceivable that there was a low level of infec-
tion in one animal. If the animals were exposed to BVD virus
during the trial, however, the minimal incidence of positive sam-
ples would suggest that the animals were well protected by vacci-
nation. Given the high incidence of neosporosis detected in the
FIG 2 Microsatellite PCR products run on 4% agarose gels to aid in strain
identification. (A) Nc-S197 (lanes 3 and 9) and Nc-Nowra (lanes 2 and 8)
genomic DNA standards and samples from group 2 heifer 121 brain rostral
lobe (010R, lane 4); brain stem (010S, lanes 5 and 6); fetal brain from calf of
NTX heifer 108 (047M, lane 7). (B) S2, serum from uninfected sentinel heifer
(lane 2); S7, S8, and S9 (lanes 3, 4, and 7, respectively), serum from a group 1
heifer that aborted, collected 0, 30, and 60 days postchallenge, respectively;
S197 (lanes 6 and 10) and Nc-Nowra (lanes 5 and 9) genomic DNA; S11 (lane
8), serum collected 30 days postchallenge from a group 2 heifer containing a
fetal calf with a PCR-positive spleen.
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fetuses and the minimal incidence of BVD virus-positive samples,
it is unlikely that BVD virus played a role in the abortions seen in
this study. It has been suggested based on mouse studies with
Leishmania major (17) and Toxoplasma gondii (18) that induction
of Th1 cytokine responses might interfere with fetal implantation
and development of normal pregnancy. Since vaccination of cattle
with live Neospora tachyzoites is expected to induce such cytokine
responses (11, 19, 20), it is possible that this response to the vac-
cine affected the pregnancy rates in this study. Although it would
be expected that the cytokine response to vaccination would have
faded by the time that the animals were inseminated 2 months
later, it is conceivable that in some cases there was an active dis-
seminated infection in the early stages of pregnancy that affected
pregnancy rates. This could potentially induce an increase in pro-
inflammatory cytokines which could negatively impact embryo
implantation. The differences between treatment groups could be
a result of the robustness of the secondary cytokine response,
which could be route dependent and may also vary depending on
the medium used to prepare the vaccine, depending on how these
factors influenced the parasite burden resulting from the initial
infection. The effect of vaccination with live Neospora on subse-
quent pregnancy will need to be examined further.
This study confirms other results demonstrating that a live
attenuated vaccine against bovine neosporosis can be very effec-
tive. The results also serve to highlight some of the technical dif-
ficulties associated with the practical use of such a vaccine.
Tachyzoites preserved by freezing at 80°C did not appear to
retain the infectivity and immunogenicity of unfrozen
tachyzoites, even though tachyzoites were still viable after freezing
by this method. Preservation of the parasite using more commer-
cially acceptable methods such as lyophilization is a key hurdle in
the development of a vaccine for bovine neosporosis. Two poten-
tial safety issues were seen in this study, one being the possibility of
residual virulence of this naturally attenuated strain and the other
being the potential for negative effects of vaccination on preg-
nancy, possibly as a result of induction of Th1-type cytokine re-
sponses by vaccination with live tachyzoites. Another hurdle to
live vaccine development not addressed in this study is the poten-
tial for reversion to virulence of an attenuated strain. This could
occur during parasite proliferation if recrudescence of the infec-
tion takes place during pregnancy, should the attenuated strain
not be completely eliminated from the vaccinated animal. Passage
of the parasite from dam to offspring in the case of an incom-
pletely attenuated strain could also provide an opportunity for
reversion to virulence. Development of a completely avirulent,
stable strain of N. caninum and ensuring that the immune re-
sponse to vaccination does not interfere with pregnancy are two
additional areas of research that will be required to obtain a prac-
tical live vaccine. Although the results presented here suggest that
such a vaccine could be effective, it remains to be determined
whether it would prevent endogenous transplacental transmis-
sion from chronically infected dams to their offspring in the case
where cows became infected prior to vaccination.
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